-Lariox Pharma and Fidia Pharmaceutici Collaborate on Regulatory Excellence in Dubai In July 2023

our esteemed regulatory team had the privilege of joining Fidia Pharmaceutici's annual regulatory team meeting in Dubai. This collaborative gathering provided a valuable platform to exchange insights on the evolving regulatory landscape in Egypt.

A primary focus of the discussions centered around the latest updates in Egyptian registration processes and strategies to navigate potential challenges. Our team at Lariox Pharma emphasized the pivotal role of regulatory intelligence in identifying and overcoming bottlenecks efficiently. By leveraging our expertise, we demonstrated how proactive measures can streamline the registration process and minimize delays.

This productive exchange underscores the strong partnership between Lariox Pharma and Fidia Pharmaceutici and our shared commitment to regulatory excellence.